Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-labeling in patients with Alzheimer disease

American Journal of Neuroradiology

Volumn 30, Issue 7, 2009, Pages 1388-1393

  Yoshiura, Takashi ^a   Hiwatashi, A ^a   Yamashita, K ^a   Ohyagi, Y ^a   Monji, A ^a   Takayama, Y ^a   Nagao, E ^a   Kamano, H ^a   Noguchi, T ^a   Honda, H ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTERY BLOOD FLOW; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN REGION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; SPIN LABELING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOOD FLOW VELOCITY; BLOOD VOLUME; BRAIN; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SPIN LABELS;

EID: 68549111123     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1562     Document Type: Article

References (25)

1. Johnson KA, Mueller ST, Walshe TM, et al. Cerebral perfusion imaging in Alzheimer's disease: use of single photon emission computed tomography and iofetamine hydrochloride I 123. Arch Neurol 1987;44:165-168
2. Ishii K, Sasaki M, Yamaji S, et al. Demonstration of decreased posterior cingulate perfusion in mild Alzheimer's disease by means of H215O positron emission tomography. Eur J Nucl Med 1997;24:670-673 (Pubitemid 27299749)
3. Matsuda H. Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT. J Nucl Med 2007;48:1289-1300 (Pubitemid 47242794)
4. Hirao K, Ohnishi T, Matsuda H, et al. Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer's disease using brain perfusion single-photon emission computed tomography. Nucl Med Commun 2006;27:151-166 (Pubitemid 44391824)
5. Nagata K, Sato M, Satoh Y, et al. Hemodynamic aspects of Alzheimer's disease. Ann NY Acad Sci 2002;977:391-402
6. Detre JA, Leigh JS, Williams DS, et al. Perfusion imaging. Magn Reson Med 1992;23:37-45
7. Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 2000;47:93-100 (Pubitemid 30033655)
8. Johnson NA, Jahng G-H, Welner MW, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005;234:851-859
9. Kane I, Carpenter T, Chappell F, et al. Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: effect of lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes. Stroke 2007;38:3158-3164 (Pubitemid 350175730)
10. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
11. Petersen ET, Lim T, Golay X. Model-free arterial spin labeling quantification approach for perfusion MRI. Magn Reson Med 2006;55:219-232 (Pubitemid 43238088)
12. Look DC, Locker DR. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 1970;41:250-251
13. Canny J. A computational approach to edge-detection. IEEE Trans Pattern Anal Machine Intell 1986;8:679-698
14. Powers WJ, Grubb RL, Raichle ME. Physiological responses to focal cerebral ischemia in humans. Ann Neurol 1984;16:546-552 (Pubitemid 15211688)
15. De Reuck J, Decoo D, Hasenbroekx MC, et al. Acetazolamide vasoreactivity in vascular dementia: a positron emission tomographic study. Eur Neurol 1999;41:31-36 (Pubitemid 29043109)
16. Bonte FJ, Devous MD Sr, Reisch JS, et al. The effect of acetazolamide on regional cerebral blood flow in patients with Alzheimer's disease or stroke as measured by single-photon emission computed tomography. Invest Radiol 1989;24:99-103 (Pubitemid 19056586)
17. Knap WH, Dannenberg C, Marschall B, et al. Changes in local cerebral blood flow by neuroactivation and vasoactivation in patients with impaired cognitive function. Eur J Nucl Med 1996;23:878-888 (Pubitemid 26278786)
18. Pávics L, Grünwald F, Reichmann K, et al. Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer's dementia. Eur J Nucl Med 1999;26:239-245 (Pubitemid 29139854)
19. Meyer JS, Shirai T, Akiyama H. Neuroimaging for differentiating vascular from Alzheimer's dementias. Cerebrovasc Brain Metab Rev 1996;8:1-10 (Pubitemid 126840011)
20. Puls I, Hauck K, Demuth K, et al. Diagnostic impact of cerebral transit time in the identification of microangiopathy in dementia: a transcranial ultrasound study. Stroke 1999;30:2291-2295 (Pubitemid 29517724)
21. Hendrikse J, Petersen ET, van Laar PJ, et al. Cerebral border zones between distal end branches of intracranial arteries: MR imaging. Radiology 2008;246: 572-580 Epub 2007 Nov 30
22. Bokkers RP, van Laar PJ, van de Ven KC, et al. Arterial spin labeling MR imaging measurements of timing parameters in patients with a carotid artery occlusion. AJNR Am J Neuroradiol 2008;29:1698-1703
23. Wang J, Alsop DC, Song HK, et al. Arterial transit time imaging with flow encoding arterial spin tagging (FEAST). Magn Reson Med 2003;50:599-607 (Pubitemid 37082085)
24. Brookes MJ, Morris PG, Gowland PA, et al. Noninvasive measurement of arterial cerebral blood volume using Look-Locker EPI and arterial spin labeling. Magn Reson Med 2007;58:41-54 (Pubitemid 47229916)
25. Jahng G-H, Song E, Zhu X-P, et al. Human brain: reliability and reproducibility of pulsed arterial spin-labeling perfusion MR imaging. Radiology 2005;234: 909-916 (Pubitemid 40250837)